Trials / Unknown
UnknownNCT04985448
Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a retrospective, multi-center real world study. The real world data comes from the electronic medical record system and disease database of the research centers .The patient's demographic information, disease information, clinical treatment status, efficacy evaluation and adverse events and so on will be collected and evaluated by applicability of the data, generated an analysis data set. Use the causal inference method of statistical analysis to observe the effectiveness and safety of intravitreal injection of Conbercept, and explore the effectiveness and safety of different doses in the treatment of retinopathy of prematurity.
Conditions
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2022-10-01
- Completion
- 2022-10-01
- First posted
- 2021-08-02
- Last updated
- 2022-09-19
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04985448. Inclusion in this directory is not an endorsement.